Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for Prevention of Restenosis in PAD
NCT04277702Phase 3Unknown
- Sponsor
- Jagiellonian University
- Start
- May 2020
- Primary completion
- Oct 2023
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of montelukast in Peripheral Arterial Disease (PAD), sponsored by Jagiellonian University. Status: unknown.
02
Drugs
montelukast
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT04277702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04277702.